PO.MCB05.01 · 分子与细胞生物学
淋巴微环境保护干细胞免于恶性化命运
Lymphatic niches shield stem cells from malignant fate
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
致癌突变在年轻组织中频繁出现,但大多数在临床上保持沉默,这提示非遗传性变量可能是癌症发生的主要驱动因素。随着年龄增长,这种耐受性图景逐渐减弱,使突变细胞得以绕过约束并启动肿瘤发生。尽管癌症长期以来被视为一种衰老的标志性疾病,但近期证据表明其发病率如今在年轻个体中急剧上升,尤其是鳞状细胞癌(SCCs)。理解突变细胞在年轻时如何耐受致癌应激,以及为何这种耐受性会随时间崩溃,可能为预防性干预提供机会。这些考量在干细胞(SCs)的背景下尤为重要,干细胞是许多癌症的起源细胞,其命运与适应度受其微环境(即“微环境龛”)的严密调控。然而,先于并引导肿瘤形成的龛来源信号仍知之甚少。淋巴管系统近期被鉴定为一种干细胞龛,在肿瘤中持续被重塑,并与癌症患者转移及死亡风险升高相关。为研究淋巴龛对早期肿瘤发生的影响,我们以皮肤SCC为模型,检测了在淋巴功能缺失条件下干细胞对致癌应激的耐受性。深度容积成像显示,淋巴功能障碍使干细胞易于发生基因组不稳定,其标志是即使在无致癌物暴露的情况下,非分裂细胞中也出现DNA损伤指标(如gammaH2AX)的累积。这些发现提示,完整的淋巴龛可保护干细胞免于基因组不稳定并维持组织稳态。利用一种新型的干细胞—淋巴类器官模型,我们发现在暴露于次优致癌损伤后,与淋巴管共培养的干细胞相比于与基质细胞共培养的干细胞表现出更少的DNA损伤。为直接检验淋巴功能障碍是否加速肿瘤发生,我们在Sox9+毛囊干细胞中诱导Kras激活及p53缺失。在该模型中对淋巴管进行药理学干扰,导致诱导后三周内表皮中突变克隆扩增,并使肿瘤发生显著提前。总之,这些发现揭示了淋巴管系统在重编程干细胞对致癌应激易感性方面此前未被认识的作用。通过将淋巴完整性与基因组稳定性联系起来,这项工作凸显了淋巴驱动的调控作为一个潜在靶点,用于干细胞来源癌症(包括年龄相关的转移性疾病)的早期检测与预防。
查看英文原文 English abstract
Oncogenic mutations arise frequently in young tissues, yet most remain clinically silent, suggesting that non-genetic variables may act as major drivers of cancer initiation. With age, this landscape of tolerance gradually diminishes, allowing mutated cells to bypass restraint and initiate tumorigenesis. Although cancer has long been considered as a hallmark disease of aging, recent evidence shows its incidence is now rising sharply in younger individuals, particularly of squamous cell carcinomas (SCCs). Understanding how mutated cells tolerate oncogenic stress in youth, and why this tolerance collapses over time, may provide opportunities for preventive intervention. These considerations are particularly important in the context of stem cells (SCs) which serve as the cells of origin for many cancers and whose fate and fitness are tightly orchestrated by their microenvironment, or “niches.” Yet, the niche-derived signals that precede and direct tumor formation remain poorly understood. The lymphatic vasculature, recently identified as a SC niche, is consistently remodeled in tumors and associated with heightened risk of metastasis and death among cancer patients. To investigate the impact of the lymphatic niches on early-stage tumorigenesis, we used skin SCC as a model, and examined SC tolerance to oncogenic stress under lymphatic loss-of-function conditions. Deep volumetric imaging revealed that lymphatic dysfunction predisposes stem cells to genomic instability, marked by accumulation of DNA damage indicators such as gammaH2AX in non-dividing cells, even in the absence of carcinogen exposure. These findings suggest that intact lymphatic niches protect SCs from genomic instability and preserve tissue homeostasis. Using a novel stem cell-lymphatic organotypic model, we found that SCs co-cultured with lymphatic vessels exhibited reduced DNA damage compared to those cultured with stromal cells following exposure to suboptimal carcinogenic insults. To directly test whether lymphatic dysfunction accelerates tumorigenesis, we induced Kras activation and p53 loss in Sox9+ hair follicle SCs. Pharmacological perturbation of lymphatics in this model led expansion of mutant clones in the epidermis within three weeks post-induction and significantly earlier tumor onset. Together, these findings uncover a previously unrecognized role for the lymphatic vasculature in reprogramming stem cell vulnerability to oncogenic stress. By linking lymphatic integrity to genomic stability, this work highlights lymphatic-driven regulation as a potential target for early detection and prevention of SC-derived cancers, including age related metastatic disease.
利益披露 Disclosure
A. Goyal, None..
M. Conte, None..
S. Gur-Cohen, None.